Expertise in
8
conditions

Dr. Miguel A. Canales

Internal Medicine
Integrity Home Health Care Services
912 Wright St Ste A, 
Arlington, TX 
Accepting New Patients
Expertise in
8
conditions
Integrity Home Health Care Services
912 Wright St Ste A, 
Arlington, TX 

Overview

Miguel Canales is a primary care provider, practicing in Internal Medicine in Arlington, Texas.

Dr. Canales is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Splenectomy.

He is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 5 clinical trials. Dr. Canales is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Integrity Home Health Care Services
912 Wright St Ste A, Arlington, TX 76012

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Dual-cohort, Open-label, Phase 2 Study of Brentuximab Vedotin and CHP (A+CHP) in the Frontline Treatment of Subjects With Peripheral T-cell Lymphoma (PTCL) With Less Than 10% CD30 Expression
A Dual-cohort, Open-label, Phase 2 Study of Brentuximab Vedotin and CHP (A+CHP) in the Frontline Treatment of Subjects With Peripheral T-cell Lymphoma (PTCL) With Less Than 10% CD30 Expression
Enrollment Status: Completed
Publish Date: August 13, 2026
Intervention Type: Drug
Study Drugs: Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3
A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)
A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug
Study Drugs: Selinexor, Rituximab, Gemcitabine, Dexamethasone, Cisplatin
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)
A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)
Enrollment Status: Completed
Publish Date: December 01, 2025
Intervention Type: Biological, Drug
Study Drugs: Axicabtagene Ciloleucel, Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders, Cyclophosphamide, Fludarabine
Study Phase: Phase 3
A Phase II Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
A Phase II Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

47 Total Publications

Correction: Haemostatic changes during CART cell therapy and risk of complications.
Correction: Haemostatic changes during CART cell therapy and risk of complications.
Journal: Cancer immunology, immunotherapy : CII
Published: August 25, 2026
Similar Doctors
Expertise in
23
conditions
Dr. William R. Lumry
Internal Medicine
Expertise in
23
conditions
Dr. William R. Lumry
Internal Medicine

William R. Lumry M.D. P.A.

10100 N Central Expy Ste 100, 
Dallas, TX 
 (24.2 miles away)
214-373-7374
Languages Spoken:
English
See accepted insurances

William Lumry is a primary care provider, practicing in Internal Medicine in Dallas, Texas. Dr. Lumry is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hereditary Angioedema, Angioedema, Hives, and Primary Immunodeficiency (PID).

Expertise in
223
conditions
Dr. Yu W. Chen
Internal Medicine
Expertise in
223
conditions
Dr. Yu W. Chen
Internal Medicine
Before you request

UT Southwestern - Internal Medicine

5939 Harry Hines Blvd, 8th Fl Ste 124, 
Dallas, TX 
 (17.6 miles away)
214-645-3597
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Yu Chen is a primary care provider, practicing in Internal Medicine in Dallas, Texas. Dr. Chen is highly rated in 223 conditions, according to our data. Her clinical expertise encompasses Cerebral Hypoxia, Acute Tubular Necrosis, IgG4-Related Disease, Endovascular Embolization, and Endoscopy. Dr. Chen is currently accepting new patients.

Expertise in
30
conditions
Dr. Arturo R. Dominguez
Internal Medicine
Expertise in
30
conditions
Dr. Arturo R. Dominguez
Internal Medicine
Before you request

Dallas County Hospital District

5200 Harry Hines Blvd, 
Dallas, TX 
 (18.1 miles away)
214-590-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arturo Dominguez is a primary care provider, practicing in Internal Medicine in Dallas, Texas. Dr. Dominguez is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Cicatricial Pemphigoid, Bullous Pemphigoid, Erythema Multiforme, Stevens-Johnson Syndrome, and Angioplasty. Dr. Dominguez is currently accepting new patients.

Frequently Asked Questions about Dr. Miguel A. Canales

How do I make an appointment with Dr. Miguel A. Canales?

You can book an appointment with Dr. Miguel A. Canales by calling their office at 817-548-0625. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Miguel A. Canales a top-rated expert for Follicular Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Miguel A. Canales is classified as an Distinguished expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Miguel A. Canales specialize in?

While Dr. Miguel A. Canales is a Internal Medicine, they have specific expertise in Follicular Lymphoma, Non-Hodgkin Lymphoma, and B-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Miguel A. Canales participate in research or clinical trials?

Yes. Dr. Miguel A. Canales has published 47 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Dr. Miguel A. Canales's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Miguel A. Canales accept my insurance?

Dr. Miguel A. Canales accepts most major insurance plans, including UnitedHealthcare. We recommend calling the office directly at 817-548-0625 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Canales's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile